Serum Institute initiates phase 2, 3 clinical study for potential COVID-19 vaccine

According to the Clinical Trial Registry India, the scientific title of the study says that phase 2/3 clinical trial will be observer-blind, randomised, controlled study to determine the safety and immunogenicity of Covishield (COVID-19 vaccine) in healthy Indian adults.
Read More

Leave a Comment

Your email address will not be published. Required fields are marked *